Great talk today! As a nurse and a patient on a GLP-1 I really appreciate the discussion of destigmatizing obesity an treating it as a hormonal disease. Keep up the good work and thanks again for such a topical and personally relevant CME.
40:54 Give it about three years. There’s meds in the pipeline that will hit 30 percent of bodyweight lost, on average. That’s on par with the most potent types of bariatric surgery. 😯 The need for combination therapy for severely obese patients means that, yes, bariatric surgery isn’t going away. But next-generation GLP-1s sure may make it less practiced.
The current medications have already reduced bariatric surgery rates by 25%. Dr. Pratt highlighted the major points that they will use to try keeping bariatric surgery alive: we don't have long-term clinical studies on these medicines, if you stop taking the medications then you will regain your weight...
Quite right, Clark. The next-gen meds will simply accelerate a trend that’s already happening. But the main thing I was addressing was the “they’re not equal” statement. Yes, not NOW, they’re not… but give it about three years. The efficacy of the best GLP-1s will be on par with the most potent forms of bariatric surgery. ✅ (Btw Clark, are you going to Obesity Week next week?)
Great talk today! As a nurse and a patient on a GLP-1 I really appreciate the discussion of destigmatizing obesity an treating it as a hormonal disease. Keep up the good work and thanks again for such a topical and personally relevant CME.
Thank you! well presented.
I love it
40:54 Give it about three years.
There’s meds in the pipeline that will hit 30 percent of bodyweight lost, on average. That’s on par with the most potent types of bariatric surgery. 😯
The need for combination therapy for severely obese patients means that, yes, bariatric surgery isn’t going away. But next-generation GLP-1s sure may make it less practiced.
The current medications have already reduced bariatric surgery rates by 25%. Dr. Pratt highlighted the major points that they will use to try keeping bariatric surgery alive: we don't have long-term clinical studies on these medicines, if you stop taking the medications then you will regain your weight...
Quite right, Clark. The next-gen meds will simply accelerate a trend that’s already happening.
But the main thing I was addressing was the “they’re not equal” statement.
Yes, not NOW, they’re not… but give it about three years. The efficacy of the best GLP-1s will be on par with the most potent forms of bariatric surgery. ✅
(Btw Clark, are you going to Obesity Week next week?)
@@cloakster I am registered for Obesity Week. I haven't decided whether or not that I will attend in person.